MP 658 Pill - white round, 7mm
Pill with imprint MP 658 is White, Round and has been identified as Clonidine Hydrochloride 0.2 mg. It is supplied by Sun Pharmaceutical Industries Inc.
Clonidine is used in the treatment of ADHD; High Blood Pressure; Pain and belongs to the drug class antiadrenergic agents, centrally acting. Risk cannot be ruled out during pregnancy. Clonidine 0.2 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for MP 658
Clonidine Hydrochloride
- Imprint
- MP 658
- Strength
- 0.2 mg
- Color
- White
- Size
- 7.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Antiadrenergic agents, centrally acting
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sun Pharmaceutical Industries Inc.
- Inactive Ingredients
-
lactose,
magnesium stearate,
microcrystalline cellulose,
corn starch,
sodium starch glycolate type A potato
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 53489-0216 | Mutual Pharmaceutical Co Inc. |
| 49999-0258 | Lake Erie Medical and Surgical Supply (repackager) |
| 33358-0093 | CorePharma, LLC (repackager) |
More about clonidine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (756)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: antiadrenergic agents, centrally acting
- Breastfeeding
Patient resources
- Clonidine drug information
- Clonidine injection
- Clonidine transdermal
- Clonidine (Epidural) (Advanced Reading)
- Clonidine (Transdermal) (Advanced Reading)
Other brands
Catapres, Kapvay, Catapres-TTS, Nexiclon XR, Duraclon
Professional resources
- Clonidine monograph
- Clonidine (FDA)
- Clonidine Extended Release Tablets (FDA)
- Clonidine Injection (FDA)
- Clonidine Patch (FDA)
- Clonidine Tablets (FDA)
Other brands
Catapres, Kapvay, Catapres-TTS, Nexiclon XR, Duraclon
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
